Menu
Menu
Torrent Pharmaceuticals' stock surged by 4% to a new high of Rs 3,574 after the USFDA issued a positive Establishment Inspection Report (EIR) for its Indrad, Gujarat facility. The EIR's Voluntary Action Indicated (VAI) status signifies a successful resolution of the inspection, contributing to a significant boost in the company’s stock value. This development highlights Torrent Pharma's robust market position and promising growth prospects, as it continues to outperform the broader market and strengthen its foothold in key therapeutic areas.